Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Kangning Granules is a Traditional Chinese Medicine (TCM) formulation developed by the Beijing Beiyi Modern Traditional Chinese Medicine Technology Development Center, an entity affiliated with the Peking University Health Science Center. It is primarily utilized as a hospital preparation (医院制剂) in China for the treatment of influenza and the common cold, specifically those presenting with wind-heat symptoms. The granules are composed of multiple herbal extracts known for their heat-clearing, detoxifying, and anti-inflammatory properties. The therapeutic goal is to alleviate symptoms such as fever, headache, sore throat, and cough by modulating the body's immune response and potentially exerting direct antiviral activity against respiratory pathogens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ganmao Kangning Granules.